EMA: Scientific guideline: Concept paper on the need for the guidance on the clinical investigation of medicinal products to slow progression of renal insufficiency

Renal insufficiency and end-stage renal disease has a major impact on public health and several medicinal compounds have been licensed or are under development with the aim to halt or slow renal disease progression.